Chance Pharmaceuticals Funding: $30M Raised, Series C (2021)
Chance Pharmaceuticals is based in Hangzhou, China. It has raised $30M in total funding. Latest round: Series C.
Chance Pharmaceuticals funding overview
Chance Pharmaceuticals is based in Hangzhou, China. Chance Pharmaceuticals has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in October 2021. The round record for Chance Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Zhihua YU, Guozhong Capital, HEDA BioVenture. 3 distinct backers are named across the disclosed rounds.
Chance Pharmaceuticals at a glance
Total raised
$30M
Latest round
Series C
Latest round date
October 2021
Headquarters
Hangzhou, China
Notable investors
Zhihua YU, Guozhong Capital, HEDA BioVenture
Frequently asked about Chance Pharmaceuticals funding
How much has Chance Pharmaceuticals raised?
Chance Pharmaceuticals has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Chance Pharmaceuticals?
Zhihua YU, Guozhong Capital, HEDA BioVenture are named among the investors backing Chance Pharmaceuticals.
What was the latest Chance Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in October 2021.
Where is Chance Pharmaceuticals based?
Chance Pharmaceuticals is based in Hangzhou, China.
When did Chance Pharmaceuticals last raise?
The last disclosed Chance Pharmaceuticals round closed in October 2021 at Series C.
We update the Chance Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hangzhou and their backers are listed below.
